AdaptHealth (NASDAQ:AHCO) Director Sells $47,150.00 in Stock

AdaptHealth Corp. (NASDAQ:AHCO) Director David Solomon Williams III sold 5,000 shares of the stock in a transaction dated Thursday, December 4th. The stock was sold at an average price of $9.43, for a total transaction of $47,150.00. Following the sale, the director owned 45,045 shares of the company’s stock, valued at $424,774.35. This trade represents a 9.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

AdaptHealth Stock Performance

AdaptHealth stock traded up $0.04 during mid-day trading on Friday, reaching $9.42. 506,701 shares of the company were exchanged, compared to its average volume of 1,289,076. The firm has a market cap of $1.28 billion, a PE ratio of 17.13, a price-to-earnings-growth ratio of 1.37 and a beta of 1.77. The company has a debt-to-equity ratio of 1.09, a quick ratio of 0.86 and a current ratio of 1.08. The firm’s 50-day simple moving average is $9.31 and its two-hundred day simple moving average is $9.20. AdaptHealth Corp. has a twelve month low of $7.11 and a twelve month high of $11.63.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.05). AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The firm had revenue of $820.31 million for the quarter, compared to analysts’ expectations of $799.62 million. During the same quarter in the previous year, the company posted $0.15 EPS. The firm’s quarterly revenue was up 1.8% compared to the same quarter last year. Equities analysts predict that AdaptHealth Corp. will post 0.88 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Janney Montgomery Scott LLC boosted its position in shares of AdaptHealth by 1.9% in the 2nd quarter. Janney Montgomery Scott LLC now owns 80,301 shares of the company’s stock worth $757,000 after buying an additional 1,511 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in shares of AdaptHealth by 6.6% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 27,095 shares of the company’s stock valued at $256,000 after purchasing an additional 1,671 shares in the last quarter. CWM LLC lifted its holdings in shares of AdaptHealth by 17.5% in the third quarter. CWM LLC now owns 12,306 shares of the company’s stock valued at $110,000 after purchasing an additional 1,835 shares in the last quarter. SummerHaven Investment Management LLC increased its stake in shares of AdaptHealth by 2.4% during the 2nd quarter. SummerHaven Investment Management LLC now owns 81,771 shares of the company’s stock worth $771,000 after purchasing an additional 1,888 shares in the last quarter. Finally, Arizona State Retirement System raised its position in shares of AdaptHealth by 9.3% during the 3rd quarter. Arizona State Retirement System now owns 27,937 shares of the company’s stock worth $250,000 after purchasing an additional 2,367 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on AHCO. Canaccord Genuity Group lifted their price target on AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Wall Street Zen downgraded AdaptHealth from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 8th. Zacks Research cut shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a research note on Friday, September 19th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of AdaptHealth in a report on Tuesday. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $13.60.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.